PT Medela Potentia Tbk (MDLA) officially listed on the Indonesia Stock Exchange (IDX) on Tuesday, April 15, through an Initial Public Offering (IPO). Following its public debut, the company will prioritize building a factory, purchasing a warehouse, and increasing production capacity aimed at vertical integration.

“We are currently making wound care products, basically plasters. The stickiness varies, and most are made in Europe, where the humidity is different. By becoming a producer, we can do vertical integration,” said President Director Krestijanto Panji on April 15.

Production Strategy: Expanding Local Capabilities in Wound Care

Krestijanto emphasized the importance of localizing production for wound care products, citing environmental differences between Indonesia and Europe. MDLA seeks to gain better control over quality and supply through local manufacturing.

With vertical integration as the central strategy, the company plans to reduce reliance on foreign manufacturers and improve product compatibility with local conditions.

Exploring Cross-Border Manufacturing Partnerships

MDLA is currently exploring production cooperation with international partners, including companies in China. According to Krestijanto, interest from Chinese investors is growing.

“China also has many that want to come in (invest). We are exploring with companies in China,” he stated.

Targeting Regional Distribution in Southeast Asia

In addition to production efforts, MDLA plans to expand distribution through regional partnerships. The company is in talks with a business in the Philippines and is considering opportunities in other Southeast Asian markets.

“So far, there have been talks with one company in the Philippines, and we’re still thinking about the others, such as Vietnam or Thailand,” said Krestijanto.

MDLA Revenue Reaches IDR 14 Trillion, Sets 2025 Growth Target

Over the past year, MDLA posted unaudited revenue of IDR 14 trillion. The company recorded annual growth of around 11% to 12% compared to 2023 and is targeting the same growth rate for 2025.

“For 2025, we are targeting revenue growth of around 11%–12%,” Krestijanto added.

PHOTO: BEI

This article was created with AI assistance.